Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP572898.RADX2fUYEVfzvB39OTv4aGTaTyacRR0DXOEwSQFjeGewY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP572898.RADX2fUYEVfzvB39OTv4aGTaTyacRR0DXOEwSQFjeGewY130_assertion type Assertion NP572898.RADX2fUYEVfzvB39OTv4aGTaTyacRR0DXOEwSQFjeGewY130_head.
- NP572898.RADX2fUYEVfzvB39OTv4aGTaTyacRR0DXOEwSQFjeGewY130_assertion wasGeneratedBy ECO_0000203 NP572898.RADX2fUYEVfzvB39OTv4aGTaTyacRR0DXOEwSQFjeGewY130_provenance.
- NP572898.RADX2fUYEVfzvB39OTv4aGTaTyacRR0DXOEwSQFjeGewY130_assertion wasDerivedFrom befree-20140225 NP572898.RADX2fUYEVfzvB39OTv4aGTaTyacRR0DXOEwSQFjeGewY130_provenance.
- NP572898.RADX2fUYEVfzvB39OTv4aGTaTyacRR0DXOEwSQFjeGewY130_assertion SIO_000772 15300803 NP572898.RADX2fUYEVfzvB39OTv4aGTaTyacRR0DXOEwSQFjeGewY130_provenance.
- NP572898.RADX2fUYEVfzvB39OTv4aGTaTyacRR0DXOEwSQFjeGewY130_assertion evidence source_evidence_literature NP572898.RADX2fUYEVfzvB39OTv4aGTaTyacRR0DXOEwSQFjeGewY130_provenance.
- NP572898.RADX2fUYEVfzvB39OTv4aGTaTyacRR0DXOEwSQFjeGewY130_assertion description "[Our study strongly supports the use of Ad-CD40L and Ad-IL-2 combination therapy for the treatment of patients with B cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP572898.RADX2fUYEVfzvB39OTv4aGTaTyacRR0DXOEwSQFjeGewY130_provenance.